|
2006 Archive |
|
|
|
|
|
Biotech Monthly newsletter |
|
| November 2006 -
35 pgs. Main Story: Uncertainty versus money flow |
|
|
|
| October 2006 -
45 pgs. Main Story: Politics and the future of biotech |
|
|
|
| September 2006 -
33 pgs. Main Story: Altus Pharmaceuticals (ALTU) |
|
|
|
| August 2006 -
212
pgs.
Biotech Monthly Fifth Annual
Anniversary Issue |
|
| If you are
interested in biotech, you cannot miss this issue. 200+ pages
detailing the outlook for all 25 companies in our
coverage universe. Our most popular issue and considered by some to
be the "handbook" for biotech investing for the second half of
the year. Also available for single-issue purchase. |
|
|
|
| July 2006 -
37 pgs. Main Story: Dynavax leads the TLR pack |
|
|
|
| June 2006 -
38 pgs. Main Story: OvaRex provides window to advances in
immunotherapy |
|
|
|
| May 2006 -
37 pgs. Main Story: Inside Clinical Trials |
|
|
|
| April 2006 -
21 pgs. Main Story: ViRexx (REX) |
|
|
|
| March 2006 -
27 pgs. Main Story: Macro commentary: Pause or Pullback |
|
|
|
| February 2006 -
40 pgs. Main Story: Zonagen (ZONA) and Hana Biosciences (HBX) |
|
|
|
| January 2006 -
34 pgs. Main Story: Praecis Pharmaceuticals (PRCS) |
|
|
|
| BSR
Alerts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06/06/2006 - 1:40am EDT |
SciClone |
| |
